Date of filling in this questionnaire or last update: 21/09/2020
1. IDENTIFICATION & BASIC DESCRIPTION
Cohort name
  Nightingale
Country
 

  • Netherlands

Name
  Roel Vermeulen
Institution
  Utrecht University
Email
  r.c.h.vermeulen@uu.nl
Website
 

  • http://www.nightingale-studie.nl/

Name of committee
  Ethics review committee at the Netherlands Cancer Institute
Upload files
 

Or provide website
 

  • http://www.nightingale-studie.nl/

Contact Principal Investigator (name)
  Roel Vermeulen
Is this cohort part of a consortium? (name consortium)
  LIFEWORK
Participation in pooled analyses
 

  • The cohort is potentially interested in participating in pooled analyses of (European) occupational cohort studies (note pooled analyses also includes remote decentralized analyses that would not require any transfer of primary data as well as meta-analyses).

Main aim of cohort, please briefly describe the main objectives of the cohort
  shift work and breast cancer risk among nurses
Study design (please select as many as appropriate)
 

  • Prospective cohort

Source population (please select as many as appropriate)
 

  • General population: National

Comparators (please select as many as appropriate)
 

  • Internal study population

Inclusion criteria
  18 to 65 year old female BIG-registered nurses with a residential address in the Netherlands
Exclusion criteria
  none
Enrollment
  Completed
Age range at entry (main cohort)
 

Minimum Maximum Mean
18 65

Men at enrollment
  0
Women at enrollment
  59947
Children (<18 years) at enrollment
  0
Participation rate at enrollment (if known)
  31
2. OUTCOME FOLLOW-UP
Type of data for outcome follow-up (please select as many as appropriate)
 

  • Use of registers (specify)

Specify: Use of registers
 

  • Netherlands Cancer Registry; National Pathology Database; Statistics Netherlands (CBS)

First follow-up period (provide year)
  2017
Number of follow-ups after baseline (provide number)
  1
3. OCCUPATIONAL EXPOSURES
Source of exposure data collected (please select as many as appropriate)
 

  • Questionnaire, Personal (Self-reporting or interview)
  • Questionnaire, Personal (Occupational/industry modules)

Occupational history/time frame
  Lifetime
Occupational coding performed
  No
Methods for exposure assessment (please select as many as appropriate)
 

  • Self-report

Main categories
 

  • Solvents
  • Other chemicals
  • Physical agents
  • Organisation of work including working time

Other chemicals | Detergents and cleaning products
 

  • Cleaning products

Physical agents
 

  • Light-at-night (LAN)
  • Radiation

Physical agents | Radiation
 

  • Ionising
  • Non-ionising

Physical agents | Work/non-work interface
 

  • Work-family (work-home) interface/conflict/balance

Organisation of work including working time | Shift work
 

  • Night (permanent or rotating)

4. OUTCOMES EVALUATED
Baseline - type of outcome data collected (select more than one if applicable)
 

  • Questionnaire, individual (self-recording or interview)

Follow-up - type of outcome data collected (select more than one if applicable)
 

  • Questionnaire, individual (self-recording or interview)

Outcome type (please select as many as appropriate)
 

  • Mortality
  • Morbidity

Diagnostic groups based on ICD10
 

  • C + D Neoplasms

C + D Neoplasms
 

  • Benign neoplasm
  • Carcinoma in situ
  • Leukemia
  • Malignant neoplasms gastro intes. system including liver, gall bladder, pancreas
  • Malignant neoplasm lung
  • Mesothelioma
  • Other malignant neoplasm of respiratory and intrathoracic organs, heart, pleura
  • Malignant neoplasm of bone and articular cartilage
  • Melanoma and other malignant neoplasms of skin
  • Neoplasms connective and soft tissue including nerves
  • Malignant neoplasm of breast
  • Malignant neoplasms, females gynecological
  • Malignant neoplasms of male genital organs
  • Malignant neoplasm of urinary tract and kidney
  • Malignant neoplasms of eye, brain and other parts of central nervous system
  • Malignant neoplasms of thyroid and other endocrine glands
  • Malignant neoplasms of ill-defined, secondary and unspecified sites
  • Malignant neoplasm without specification of site including excl. leukemia
  • Other, please state

5. BIOLOGICAL SAMPLES & ANALYSIS
Biological samples collected
 

  • Nails

Biological processing
 

  • DNA

Genetic and other lab analyses
 

  • Genomics / GWAS

6. Other Information
 

  • Alcohol
  • Anthropometry
  • Demographics
  • Diet
  • Education
  • Environmental, air pollution
  • Medical history
  • Personality
  • Physical exercise
  • Residential history
  • Socioeconomic status
  • Smoking

Possibility for linkage to data registries/data enrichment via data linkage
 

  • Cancer incidence